Curis, Inc. To Present At The Oppenheimer 24th Annual Healthcare Conference

LEXINGTON, Mass., Dec. 4, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused drug development company seeking to develop novel drug candidates for the treatment of human cancers, today announced that the Company will present at the Oppenheimer 24th Annual Healthcare Conference at 2:45 p.m. ET on December 11, 2013, in New York City.

Help employers find you! Check out all the jobs and post your resume.